InFocus launches digital ventures strategy with Mythos Group to push into Blockchain, AI and BitcoinInFocus launches digital ventures strategy with Mythos Group to push into Blockchain, AI and Bitcoin

InFocus launches digital ventures strategy with Mythos Group to push into Blockchain, AI and Bitcoin

SYDNEY, Sept. 1, 2025 /PRNewswire/ -- InFocus Group Holdings Limited (ASX: IFG) (InFocus), a data analytics and software solutions company,  has unveiled InFocus Digital Ventures, a new unit dedicated to blockchain, digital assets, AI, and frontier technologies – backed by an AUD 10 million financing facility from Asia-Pacific digital asset powerhouse Mythos Group.

"InFocus Digital Ventures is where our existing product and services platform meets the future of digital assets," said Ken Tovich, CEO of InFocus. "With Mythos as a long-term partner, we now have the capital, the expertise, and the structure to launch ventures in blockchain, AI, and Bitcoin – and we're doing it in a way that is intended to be revenue accretive and strategically aligned from the start."

By the end of this week, InFocus will draw an initial AUD 2.5 million under the facility. Proceeds will be immediately invested into the Monochrome Bitcoin ETF (CBOE: IBTC), giving InFocus institutional-grade indirect exposure to Bitcoin while maintaining the ability to realise the investment in either cash or Bitcoin as strategic opportunities arise.

The full AUD 10 million convertible note issuance remains subject to shareholder and regulatory approvals. Mythos and other investors are subject to long-dated lockups of up to 360 days on any issued shares, a structure specifically designed to reinforce long-term alignment between Mythos and InFocus.

InFocus Digital Ventures will serve as the launchpad for projects that combine the InFocus' proven capabilities in AI, cybersecurity, and software development with a view to being a leading blockchain-enabled service provider.

For further information, please contact:

InFocus Group Holdings Limitede: IFG@reignadvisory.comp: +61 2 9174 5388

About InFocus Group Holdings Limited

InFocus Group Holdings Limited (IFG) is a data intelligence and software solutions company with proven expertise in data analytics as well as software and platform development. IFG has enterprise-scale capabilities across data analytics, business intelligence, software and platform development, cybersecurity, artificial intelligence and machine learning, and team augmentation.

About Mythos Group

Mythos Group is a multi-strategy digital asset holding company with a strong presence in the Asia-Pacific region. The firm invests across the digital asset ecosystem - backing early-stage crypto startups while also directly participating in Bitcoin-backed corporate treasury strategies, PIPE transactions, and regulated crypto platforms.

By working with partners who have a deep understanding of local market dynamics, Mythos seeks to drive blockchain adoption by facilitating the flow of sidelined capital from traditional markets into the digital asset space.

Disclaimer: This is a sponsored press release and is for informational purposes only. It does not reflect the views of Crypto Daily, nor is it intended to be used as legal, tax, investment, or financial advice.

Market Opportunity
EPNS Logo
EPNS Price(PUSH)
$0.01084
$0.01084$0.01084
-2.69%
USD
EPNS (PUSH) Live Price Chart
Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact service@support.mexc.com for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.

You May Also Like

Over $145M Evaporates In Brutal Long Squeeze

Over $145M Evaporates In Brutal Long Squeeze

The post Over $145M Evaporates In Brutal Long Squeeze appeared on BitcoinEthereumNews.com. Crypto Futures Liquidations: Over $145M Evaporates In Brutal Long Squeeze
Share
BitcoinEthereumNews2026/01/16 11:35
Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution

Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution

The post Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution appeared on BitcoinEthereumNews.com. In this week’s edition of InnovationRx, we look at possible pain treatments from cannabis, risks of new vaccine restrictions, virtual clinical trials at the Mayo Clinic, GSK’s $30 billion U.S. manufacturing commitment, and more. To get it in your inbox, subscribe here. Despite their addictive nature, opioids continue to be a major treatment for pain due to a lack of effective alternatives. In an effort to boost new drugs, the FDA released new guidelines for non-opioid painkillers last week. But making these drugs hasn’t been easy. Vertex Pharmaceuticals received FDA approval for its non-opioid Journavx in January, then abandoned a next generation drug after a failed clinical trial earlier this summer. Acadia similarly abandoned a promising candidate after a failed trial in 2022. One possible basis for non-opioids might be cannabis. Earlier this year, researchers at Washington University at St. Louis and Stanford published a study showing that a cannabis-derived compound successfully eased pain in mice with minimal side effects. Munich-based pharmaceutical company Vertanical is perhaps the furthest along in this quest. It is developing a cannabinoid-based extract to treat chronic pain it hopes will soon become an approved medicine, first in the European Union and eventually in the United States. The drug, currently called Ver-01, packs enough low levels of cannabinoids (including THC) to relieve pain, but not so much that patients get high. Founder Clemens Fischer, a 50-year-old medical doctor and serial pharmaceutical and supplement entrepreneur, hopes it will become the first cannabis-based painkiller prescribed by physicians and covered by insurance. Fischer founded Vertanical, with his business partner Madlena Hohlefelder, in 2017, and has invested more than $250 million of his own money in it. With a cannabis cultivation site and drug manufacturing plant in Denmark, Vertanical has successfully passed phase III clinical trials in Germany and expects…
Share
BitcoinEthereumNews2025/09/18 05:26
Edges higher ahead of BoC-Fed policy outcome

Edges higher ahead of BoC-Fed policy outcome

The post Edges higher ahead of BoC-Fed policy outcome appeared on BitcoinEthereumNews.com. USD/CAD gains marginally to near 1.3760 ahead of monetary policy announcements by the Fed and the BoC. Both the Fed and the BoC are expected to lower interest rates. USD/CAD forms a Head and Shoulder chart pattern. The USD/CAD pair ticks up to near 1.3760 during the late European session on Wednesday. The Loonie pair gains marginally ahead of monetary policy outcomes by the Bank of Canada (BoC) and the Federal Reserve (Fed) during New York trading hours. Both the BoC and the Fed are expected to cut interest rates amid mounting labor market conditions in their respective economies. Inflationary pressures in the Canadian economy have cooled down, emerging as another reason behind the BoC’s dovish expectations. However, the Fed is expected to start the monetary-easing campaign despite the United States (US) inflation remaining higher. Investors will closely monitor press conferences from both Fed Chair Jerome Powell and BoC Governor Tiff Macklem to get cues about whether there will be more interest rate cuts in the remainder of the year. According to analysts from Barclays, the Fed’s latest median projections for interest rates are likely to call for three interest rate cuts by 2025. Ahead of the Fed’s monetary policy, the US Dollar Index (DXY), which tracks the Greenback’s value against six major currencies, holds onto Tuesday’s losses near 96.60. USD/CAD forms a Head and Shoulder chart pattern, which indicates a bearish reversal. The neckline of the above-mentioned chart pattern is plotted near 1.3715. The near-term trend of the pair remains bearish as it stays below the 20-day Exponential Moving Average (EMA), which trades around 1.3800. The 14-day Relative Strength Index (RSI) slides to near 40.00. A fresh bearish momentum would emerge if the RSI falls below that level. Going forward, the asset could slide towards the round level of…
Share
BitcoinEthereumNews2025/09/18 01:23